KAM
Krensavage Asset Management Portfolio holdings
AUM
$189M
This Quarter Return
-11.16%
1 Year Return
+19.71%
3 Year Return
+56.44%
5 Year Return
+120.01%
10 Year Return
+215.64%
AUM
$276M
AUM Growth
+$276M
(+4.2%)
Cap. Flow
+$45.2M
Cap. Flow
% of AUM
16.36%
Top 10 Holdings %
Top 10 Hldgs %
70.09%
Holding
23
New
1
Increased
19
Reduced
2
Closed
–
Top Buys
| 1 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
$22.7M |
| 2 |
United Therapeutics
UTHR
|
$6.66M |
| 3 |
Amgen
AMGN
|
$4.77M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$3.56M |
| 5 |
Orthofix Medical
OFIX
|
$2.93M |
Top Sells
| 1 |
SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
|
$8.73M |
| 2 |
JNP
Juniper Pharmaceuticals, Inc. Common Stock
JNP
|
$564K |
Sector Composition
| 1 | Healthcare | 69.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Enanta Pharmaceuticals
ENTA
$180M
| $26.4M | 9.55% | 730,308 +23,400 | +3% | +$846K |
|
|
2
United Therapeutics
UTHR
$13.8B
| $26.2M | 9.48% | 199,573 +50,715 | +34% | +$6.66M |
|
|
BXLT
3
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $22.7M | 8.23% | +721,800 | New | +$22.7M |
|
|
4
Teva Pharmaceuticals
TEVA
$21.1B
| $21.1M | 7.62% | 373,062 +63,100 | +20% | +$3.56M |
|
|
5
Orthofix Medical
OFIX
$592M
| $20.6M | 7.46% | 610,247 +86,800 | +17% | +$2.93M |
|
|
IPXL
6
DELISTED
Impax Laboratories, Inc.
IPXL
| $18.7M | 6.77% | 530,875 +75,400 | +17% | +$2.66M |
|
7
Avanos Medical
AVNS
$554M
| $15.2M | 5.52% | 535,943 +99,700 | +23% | +$2.84M |
|
|
8
Amgen
AMGN
$155B
| $14.3M | 5.18% | 103,536 +34,450 | +50% | +$4.77M |
|
9
CONMED
CNMD
$1.68B
| $13.1M | 4.74% | 274,528 +9,100 | +3% | +$434K |
|
10
Merck
MRK
$210B
| $12.3M | 4.46% | 249,503 +27,400 | +12% | +$1.35M |
|
|
HRC
11
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $10.7M | 3.87% | 205,713 +6,600 | +3% | +$343K |
|
|
SCMP
12
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $10.5M | 3.8% | 528,175 -439,229 | -45% | -$8.73M |
|
|
SRGA
13
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $10.4M | 3.76% | 1,828,672 +58,600 | +3% | +$333K |
|
14
Assertio
ASRT
$80.4M
| $7.08M | 2.56% | 375,387 +12,500 | +3% | +$236K |
|
|
AGN
15
DELISTED
Allergan plc
AGN
| $6.59M | 2.39% | 24,240 +950 | +4% | +$258K |
|
|
SPPI
16
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $6.45M | 2.33% | 1,078,502 +234,800 | +28% | +$1.4M |
|
|
IVC
17
DELISTED
Invacare Corporation
IVC
| $5.82M | 2.11% | 402,382 +48,750 | +14% | +$705K |
|
|
VXRT
18
DELISTED
Vaxart
VXRT
| $5.09M | 1.84% | 2,570,577 +932,085 | +57% | +$1.85M |
|
|
JNP
19
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
| $3.3M | 1.19% | 279,717 -47,900 | -15% | -$564K |
|
|
STRR
20
DELISTED
Star Equity Holdings
STRR
| $1.71M | 0.62% | 457,699 +14,600 | +3% | +$54.6K |
|
|
FURX
21
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
| $1.42M | 0.51% | 145,544 | – | – |
|
22
Innoviva
INVA
$1.29B
| $1.26M | 0.46% | 176,108 +5,800 | +3% | +$41.6K |
|